Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 22,366 | reported | 02 Mar 2026 | tx 123+338,267−223,334 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 3,262 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 7,500 | 0.00 USD | |
| 02 Mar 2026 | SALE | Krystal Biotech, Inc. | 750 | 267.60 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 240 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 550 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 5,442 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 550 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 7,500 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 13,575 | 0.00 USD | deriv |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 400 | 275.68 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 96 | 277.88 USD | |
| 09 Feb 2026 | GIFT | Krystal Biotech, Inc. | 750 | 0.00 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 2,824 | 272.51 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 552 | 274.64 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 928 | 273.71 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 5,700 | 271.66 USD | |
| 09 Feb 2026 | SALE | Krystal Biotech, Inc. | 2,000 | 270.56 USD | |
| 09 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 12,500 | 63.55 USD | |
| 09 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 12,500 | 0.00 USD | deriv |
| 28 Feb 2025 | EXERCISE | Krystal Biotech, Inc. | 5,000 | 0.00 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 3,471 | 179.25 USD | |
| 28 Feb 2025 | EXERCISE | Krystal Biotech, Inc. | 7,500 | 0.00 USD | |
| 26 Feb 2025 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 2,268 | 176.39 USD | |
| 27 Feb 2025 | SALE | Krystal Biotech, Inc. | 750 | 175.22 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 2,315 | 179.25 USD |